Ulrika Andersson

3.5k total citations
29 papers, 692 citations indexed

About

Ulrika Andersson is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ulrika Andersson has authored 29 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Ulrika Andersson's work include Glioma Diagnosis and Treatment (13 papers), Drug Transport and Resistance Mechanisms (4 papers) and Epigenetics and DNA Methylation (4 papers). Ulrika Andersson is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Drug Transport and Resistance Mechanisms (4 papers) and Epigenetics and DNA Methylation (4 papers). Ulrika Andersson collaborates with scholars based in Sweden, United States and Denmark. Ulrika Andersson's co-authors include Roger Henriksson, Beatrice Melin, Beatrice Malmer, A. Tommy Bergenheim, Thomas Brännström, Carl Wibom, Dongsheng Guo, Göran Roos, Anna M. Dahlin and Gunnar Johansson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Ulrika Andersson

29 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrika Andersson Sweden 14 376 294 194 131 99 29 692
Sylwester Piaskowski Poland 16 337 0.9× 240 0.8× 161 0.8× 222 1.7× 50 0.5× 39 704
Jeremy McGuire United States 10 320 0.9× 237 0.8× 257 1.3× 188 1.4× 111 1.1× 20 740
Gerardo Ferrer United States 19 439 1.2× 398 1.4× 278 1.4× 175 1.3× 50 0.5× 45 1.2k
Kah Suan Lim United States 10 538 1.4× 177 0.6× 173 0.9× 157 1.2× 42 0.4× 14 754
Marta Viana‐Pereira Portugal 14 422 1.1× 363 1.2× 277 1.4× 178 1.4× 123 1.2× 23 787
Yolanda Ruano Spain 13 314 0.8× 270 0.9× 147 0.8× 147 1.1× 111 1.1× 40 712
Hendrik Nogai Germany 15 404 1.1× 216 0.7× 262 1.4× 340 2.6× 156 1.6× 35 1.0k
Balaram Thota India 12 318 0.8× 208 0.7× 277 1.4× 110 0.8× 85 0.9× 15 598
Ana Guerreiro Stücklin Switzerland 15 445 1.2× 350 1.2× 121 0.6× 127 1.0× 107 1.1× 31 774
Jizong Zhao China 16 479 1.3× 254 0.9× 448 2.3× 145 1.1× 131 1.3× 38 887

Countries citing papers authored by Ulrika Andersson

Since Specialization
Citations

This map shows the geographic impact of Ulrika Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Andersson more than expected).

Fields of papers citing papers by Ulrika Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Andersson. The network helps show where Ulrika Andersson may publish in the future.

Co-authorship network of co-authors of Ulrika Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika Andersson. A scholar is included among the top collaborators of Ulrika Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika Andersson. Ulrika Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wendy, Gunnar Johansson, Carl Wibom, et al.. (2019). The Genetic Architecture of Gliomagenesis–Genetic Risk Variants Linked to Specific Molecular Subtypes. Cancers. 11(12). 2001–2001. 10 indexed citations
2.
Andersson, Ulrika, Sofie Degerman, Anna M. Dahlin, et al.. (2018). The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking. Cancer Causes & Control. 30(2). 177–185. 7 indexed citations
3.
Wibom, Carl, et al.. (2016). Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Journal of Neuro-Oncology. 127(3). 483–492. 28 indexed citations
4.
Andersson, Ulrika, Anna M. Dahlin, Hilde Langseth, et al.. (2016). Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumor Biology. 37(8). 11065–11072. 7 indexed citations
5.
Dahlin, Anna M., et al.. (2016). Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor. PLoS ONE. 11(10). e0163067–e0163067. 10 indexed citations
6.
Wibom, Carl, Anna M. Dahlin, Hilde Langseth, et al.. (2015). Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 24(5). 810–816. 15 indexed citations
7.
Dahlin, Anna M., Mads V. Hollegaard, Carl Wibom, et al.. (2015). CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma. Journal of Neuro-Oncology. 125(1). 75–78. 14 indexed citations
8.
Wibom, Carl, Peter Van Loo, Thomas Brännström, et al.. (2012). EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma. PLoS ONE. 7(12). e47929–e47929. 12 indexed citations
9.
Haapasalo, Hannu, Mine Eray, Katariina Korhonen, et al.. (2012). Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression. Journal of Neuro-Oncology. 108(3). 435–441. 11 indexed citations
10.
Berntsson, Shala Ghaderi, Carl Wibom, Roger Henriksson, et al.. (2011). Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas. Journal of Neuro-Oncology. 105(3). 531–538. 4 indexed citations
11.
Sjöström, Stefan, Carl Wibom, Ulrika Andersson, et al.. (2010). Genetic variations in VEGF and VEGFR2 and glioblastoma outcome. Journal of Neuro-Oncology. 104(2). 523–527. 23 indexed citations
12.
Andersson, Ulrika, Judith Schwartzbaum, Fredrik Wiklund, et al.. (2010). A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncologica. 49(6). 767–775. 62 indexed citations
13.
Andersson, Ulrika, Pia Osterman, Christoffer Johansen, et al.. (2009). MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. International Journal of Cancer. 125(4). 968–972. 24 indexed citations
14.
Andersson, Ulrika, Roberta McKean‐Cowdin, Ulf Hjalmars, & Beatrice Malmer. (2009). Genetic variants in association studies – review of strengths and weaknesses in study design and current knowledge of impact on cancer risk. Acta Oncologica. 48(7). 948–954. 10 indexed citations
15.
Andersson, Ulrika, et al.. (2007). Treatment schedule is of importance when gefitinib is combined with irradiation of glioma and endothelial cellsin vitro. Acta Oncologica. 46(7). 951–960. 13 indexed citations
16.
Andersson, Ulrika, et al.. (2004). Heterogeneity in the expression of markers for drug resistance in brain tumors.. PubMed. 23(1). 21–7. 37 indexed citations
17.
Sandström, Maria, Mattias Johansson, Ulrika Andersson, et al.. (2004). The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model. British Journal of Cancer. 91(6). 1174–1180. 38 indexed citations
18.
Andersson, Ulrika, et al.. (2004). Epidermal growth factor receptor family (EGFR, ErbB2?4) in gliomas and meningiomas. Acta Neuropathologica. 108(2). 135–42. 121 indexed citations
19.
Malmer, Beatrice, et al.. (2003). Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?. PubMed. 22(6C). 3949–54. 5 indexed citations
20.
Henriksson, Roger, Ulrika Andersson, Kjell Grankvist, et al.. (2002). Rapid Induction of Long-Lasting Drug Efflux Activity in Brain Vascular Endothelial Cells But Not Malignant Glioma Following Irradiation. Medical Oncology. 19(1). 1–10. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylwester Piaskowski Breakdown of academic impact, for papers by Jeremy McGuire Breakdown of academic impact, for papers by Gerardo Ferrer Breakdown of academic impact, for papers by Kah Suan Lim Breakdown of academic impact, for papers by Marta Viana‐Pereira Breakdown of academic impact, for papers by Yolanda Ruano Breakdown of academic impact, for papers by Hendrik Nogai Breakdown of academic impact, for papers by Balaram Thota Breakdown of academic impact, for papers by Ana Guerreiro Stücklin Breakdown of academic impact, for papers by Jizong Zhao
Rankless by CCL
2026